5-Lipoxygenase inhibitors suppress RANKL-induced osteoclast formation via NFATc1 expression
Ju-Hee Kang(Sookmyung Women's University), Mijung Yim(Sookmyung Women's University), Jung-Seon Sim(Sookmyung Women's University), Hyeun Wook Chang(Yeungnam University), Sunhye Hong(Ewha Womans University), Jung Min Lee(Kyung Hee University), Mi-ran Moon(Sookmyung Women's University), Kyung‐Eun Doh(Ewha Womans University), Minghua Cui(Ewha Womans University), Ting Zheng(Xuzhou Medical College), Hea-Young Park Choo(Ewha Womans University), Sun Choi(Ewha Womans University)
Cited by 21
Related Papers
Precisely printable and biocompatible silk fibroin bioink for digital light processing 3D printing
|Nature Communications|2018|964
Selective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea
|The Journal of Clinical Endocrinology & Metabolism|2003|650
Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study
|The Lancet Oncology|2014|586
Chameleon-Inspired Mechanochromic Photonic Films Composed of Non-Close-Packed Colloidal Arrays
|ACS Nano|2017|415
Validity of Consumer-Based Physical Activity Monitors
|Medicine & Science in Sports & Exercise|2014|412